354 related articles for article (PubMed ID: 30669566)
1. Clinical Use and Molecular Action of Corticosteroids in the Pediatric Age.
Ferrara G; Petrillo MG; Giani T; Marrani E; Filippeschi C; Oranges T; Simonini G; Cimaz R
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669566
[TBL] [Abstract][Full Text] [Related]
2. Specificity and sensitivity of glucocorticoid signaling in health and disease.
Cain DW; Cidlowski JA
Best Pract Res Clin Endocrinol Metab; 2015 Aug; 29(4):545-56. PubMed ID: 26303082
[TBL] [Abstract][Full Text] [Related]
3. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah V; Ohlsson A; Halliday HL; Dunn MS
Cochrane Database Syst Rev; 2000; (2):CD001969. PubMed ID: 10796275
[TBL] [Abstract][Full Text] [Related]
4. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus.
Goulding NJ
Curr Opin Pharmacol; 2004 Dec; 4(6):629-36. PubMed ID: 15525555
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids.
Spies CM; Strehl C; van der Goes MC; Bijlsma JW; Buttgereit F
Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):891-900. PubMed ID: 22265268
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacology of glucocorticoids and ENT pathology].
Devillier P
Presse Med; 2001 Dec 22-29; 30(39-40 Pt 2):59-69. PubMed ID: 11819915
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of action of corticosteroids in asthma.
Taylor IK; Shaw RJ
Respir Med; 1993 May; 87(4):261-77. PubMed ID: 9728226
[No Abstract] [Full Text] [Related]
9. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
[TBL] [Abstract][Full Text] [Related]
10. The search for safer glucocorticoid receptor ligands.
Rosen J; Miner JN
Endocr Rev; 2005 May; 26(3):452-64. PubMed ID: 15814846
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of action of glucocorticoids].
Dejean C; Richard D
Rev Med Interne; 2013 May; 34(5):264-8. PubMed ID: 23498716
[TBL] [Abstract][Full Text] [Related]
12. Non-genomic Effects of Glucocorticoids: An Updated View.
Panettieri RA; Schaafsma D; Amrani Y; Koziol-White C; Ostrom R; Tliba O
Trends Pharmacol Sci; 2019 Jan; 40(1):38-49. PubMed ID: 30497693
[TBL] [Abstract][Full Text] [Related]
13. Optimized glucocorticoid therapy: teaching old drugs new tricks.
Strehl C; Buttgereit F
Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
[TBL] [Abstract][Full Text] [Related]
14. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
Stahn C; Löwenberg M; Hommes DW; Buttgereit F
Mol Cell Endocrinol; 2007 Sep; 275(1-2):71-8. PubMed ID: 17630118
[TBL] [Abstract][Full Text] [Related]
16. Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds.
Sundahl N; Bridelance J; Libert C; De Bosscher K; Beck IM
Pharmacol Ther; 2015 Aug; 152():28-41. PubMed ID: 25958032
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Mechanisms of Glucocorticoids.
Vandewalle J; Luypaert A; De Bosscher K; Libert C
Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of glucocorticoid actions in inflammatory joint diseases.
Baschant U; Culemann S; Tuckermann J
Mol Cell Endocrinol; 2013 Nov; 380(1-2):108-18. PubMed ID: 23769823
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.
Newton R; Leigh R; Giembycz MA
Pharmacol Ther; 2010 Feb; 125(2):286-327. PubMed ID: 19932713
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory glucocorticoids: changing concepts.
Newton R
Eur J Pharmacol; 2014 Feb; 724():231-6. PubMed ID: 23747654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
